<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Prevention | Blood Bank</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="This is truly one of the great success stories in transfusion medicine! Preventing Hemolytic Disease of the Fetus and Newborn (HDFN), particularly the severe form caused by anti-D, relies almost...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Prevention | Blood Bank">
<meta property="og:type" content="book">
<meta property="og:description" content="This is truly one of the great success stories in transfusion medicine! Preventing Hemolytic Disease of the Fetus and Newborn (HDFN), particularly the severe form caused by anti-D, relies almost...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Prevention | Blood Bank">
<meta name="twitter:description" content="This is truly one of the great success stories in transfusion medicine! Preventing Hemolytic Disease of the Fetus and Newborn (HDFN), particularly the severe form caused by anti-D, relies almost...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
<link rel="stylesheet" href="toc.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Blood Bank</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Blood Products</li>
<li><a class="" href="donors.html">Donors</a></li>
<li><a class="" href="qualification.html">Qualification</a></li>
<li><a class="" href="processing.html">Processing</a></li>
<li><a class="" href="adverse-reactions-1.html">Adverse Reactions</a></li>
<li><a class="" href="special-donations-1.html">Special Donations</a></li>
<li><a class="" href="processing-1.html">Processing</a></li>
<li><a class="" href="fda-aabb-requirements.html">FDA, AABB Requirements</a></li>
<li><a class="" href="testing.html">Testing</a></li>
<li><a class="" href="labeling.html">Labeling</a></li>
<li><a class="" href="storage.html">Storage</a></li>
<li><a class="" href="anticoagulantsadditives.html">Anticoagulants/Additives</a></li>
<li><a class="" href="temperature-requirements.html">Temperature Requirements</a></li>
<li><a class="" href="transportation.html">Transportation</a></li>
<li><a class="" href="stored-products.html">Stored Products</a></li>
<li><a class="" href="expiration.html">Expiration</a></li>
<li><a class="" href="blood-components.html">Blood Components</a></li>
<li><a class="" href="red-blood-cells.html">Red Blood Cells</a></li>
<li><a class="" href="cryoprecipitated-ahf.html">Cryoprecipitated AHF</a></li>
<li><a class="" href="platelets.html">Platelets</a></li>
<li><a class="" href="plasma.html">Plasma</a></li>
<li><a class="" href="granulocytes.html">Granulocytes</a></li>
<li><a class="" href="wbc-reduced-components.html">WBC-Reduced Components</a></li>
<li><a class="" href="frozendeglycerolized-rbcs.html">Frozen/Deglycerolized RBCs</a></li>
<li><a class="" href="apheresis-products.html">Apheresis Products</a></li>
<li><a class="" href="fractionation-products.html">Fractionation Products</a></li>
<li><a class="" href="whole-blood.html">Whole Blood</a></li>
<li><a class="" href="washed-rbcs.html">Washed RBCs</a></li>
<li><a class="" href="rejuvenated-rbcs.html">Rejuvenated RBCs</a></li>
<li><a class="" href="irradiated-components.html">Irradiated Components</a></li>
<li><a class="" href="hematopoietic-progenitors.html">Hematopoietic Progenitors</a></li>
<li><a class="" href="blood-component-qc.html">Blood Component QC</a></li>
<li class="book-part">Blood Group Systems</li>
<li><a class="" href="genetics.html">Genetics</a></li>
<li><a class="" href="basic.html">Basic</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="blood-group-inheritance.html">Blood Group Inheritance</a></li>
<li><a class="" href="biochemistryantigens.html">Biochemistry/Antigens</a></li>
<li><a class="" href="abo.html">ABO</a></li>
<li><a class="" href="lewis.html">Lewis</a></li>
<li><a class="" href="rh.html">Rh</a></li>
<li><a class="" href="mns.html">MNS</a></li>
<li><a class="" href="p1pkglobosidep.html">P1PK/Globoside(P)</a></li>
<li><a class="" href="ii.html">Ii</a></li>
<li><a class="" href="kell.html">Kell</a></li>
<li><a class="" href="kidd.html">Kidd</a></li>
<li><a class="" href="duffy.html">Duffy</a></li>
<li><a class="" href="lutheran.html">Lutheran</a></li>
<li><a class="" href="other-blood-groups.html">Other Blood Groups</a></li>
<li><a class="" href="high-prevalence-antigens.html">High Prevalence Antigens</a></li>
<li><a class="" href="low-prevalence-antigens.html">Low Prevalence Antigens</a></li>
<li><a class="" href="hla.html">HLA</a></li>
<li><a class="" href="platelet-specific.html">Platelet-Specific</a></li>
<li><a class="" href="granulocyte-specific.html">Granulocyte-Specific</a></li>
<li><a class="" href="role-of-blood-groups-in-transfusion.html">Role of Blood Groups in Transfusion</a></li>
<li><a class="" href="immunogenicity.html">Immunogenicity</a></li>
<li><a class="" href="antigen-prevalence.html">Antigen Prevalence</a></li>
<li class="book-part">Immunology &amp; Physiology</li>
<li><a class="" href="immunology.html">Immunology</a></li>
<li><a class="" href="immune-response.html">Immune response</a></li>
<li><a class="" href="primary-secondary.html">Primary &amp; Secondary</a></li>
<li><a class="" href="b-t-cells-macrophages.html">B &amp; T cells, Macrophages</a></li>
<li><a class="" href="genetics-1.html">Genetics</a></li>
<li><a class="" href="immunoglobulins.html">Immunoglobulins</a></li>
<li><a class="" href="classes-subclasses.html">Classes &amp; Subclasses</a></li>
<li><a class="" href="structure.html">Structure</a></li>
<li><a class="" href="properties.html">Properties</a></li>
<li><a class="" href="ag-ab-interactions.html">Ag-Ab Interactions</a></li>
<li><a class="" href="principles.html">Principles</a></li>
<li><a class="" href="testing-1.html">Testing</a></li>
<li><a class="" href="complement.html">Complement</a></li>
<li><a class="" href="pathway-mechanisms.html">Pathway Mechanisms</a></li>
<li><a class="" href="biologic-properties.html">Biologic Properties</a></li>
<li><a class="" href="physiology-pathophysiology.html">Physiology &amp; Pathophysiology</a></li>
<li><a class="" href="blood-physiology.html">Blood Physiology</a></li>
<li><a class="" href="circulation-volume.html">Circulation &amp; Volume</a></li>
<li><a class="" href="composition-function.html">Composition &amp; Function</a></li>
<li><a class="" href="cell-survival.html">Cell Survival</a></li>
<li><a class="" href="cell-metabolism.html">Cell Metabolism</a></li>
<li><a class="" href="hemostasis-coagulation.html">Hemostasis &amp; Coagulation</a></li>
<li><a class="" href="factors-disorders.html">Factors &amp; Disorders</a></li>
<li><a class="" href="plt-functions-disorders.html">PLT Functions &amp; Disorders</a></li>
<li><a class="" href="hdfn.html">HDFN</a></li>
<li><a class="" href="pathophysiology.html">Pathophysiology</a></li>
<li><a class="" href="detection.html">Detection</a></li>
<li><a class="" href="treatment.html">Treatment</a></li>
<li><a class="active" href="prevention.html">Prevention</a></li>
<li><a class="" href="cytopenias-1.html">Cytopenias</a></li>
<li><a class="" href="anemia.html">Anemia</a></li>
<li><a class="" href="thrombocytopenia.html">Thrombocytopenia</a></li>
<li><a class="" href="neutropenia.html">Neutropenia</a></li>
<li><a class="" href="transplantation-1.html">Transplantation</a></li>
<li><a class="" href="solid-organ.html">Solid Organ</a></li>
<li><a class="" href="hpc.html">HPC</a></li>
<li class="book-part">Serology &amp; Molecular</li>
<li><a class="" href="routine-tests.html">Routine Tests</a></li>
<li><a class="" href="blood-grouping.html">Blood Grouping</a></li>
<li><a class="" href="compatibility.html">Compatibility</a></li>
<li><a class="" href="antibody-detection.html">Antibody Detection</a></li>
<li><a class="" href="crossmatch.html">Crossmatch</a></li>
<li><a class="" href="ab-id-significance.html">Ab ID &amp; Significance</a></li>
<li><a class="" href="dat.html">DAT</a></li>
<li><a class="" href="reagents.html">Reagents</a></li>
<li><a class="" href="antiglobulin-sera.html">Antiglobulin Sera</a></li>
<li><a class="" href="blood-grouping-sera.html">Blood Grouping Sera</a></li>
<li><a class="" href="reagent-rbcs.html">Reagent RBCs</a></li>
<li><a class="" href="special-tests-reagents.html">Special Tests &amp; Reagents</a></li>
<li><a class="" href="enzymes.html">Enzymes</a></li>
<li><a class="" href="enhancement-media.html">Enhancement Media</a></li>
<li><a class="" href="lectins.html">Lectins</a></li>
<li><a class="" href="adsorptions.html">Adsorptions</a></li>
<li><a class="" href="elutions.html">Elutions</a></li>
<li><a class="" href="titrations-1.html">Titrations</a></li>
<li><a class="" href="cell-separations.html">Cell Separations</a></li>
<li><a class="" href="elisa.html">ELISA</a></li>
<li><a class="" href="molecular-techniques.html">Molecular Techniques</a></li>
<li><a class="" href="neutralization.html">Neutralization</a></li>
<li><a class="" href="thiol-reagents.html">Thiol Reagents</a></li>
<li><a class="" href="immunofluorescence.html">Immunofluorescence</a></li>
<li><a class="" href="solid-phase.html">Solid Phase</a></li>
<li><a class="" href="column-agglutination.html">Column Agglutination</a></li>
<li><a class="" href="chloroquine-diphosphate.html">Chloroquine Diphosphate</a></li>
<li><a class="" href="edta-glycine-acid.html">EDTA-Glycine Acid</a></li>
<li><a class="" href="quality-assurance.html">Quality Assurance</a></li>
<li><a class="" href="blood-samples.html">Blood Samples</a></li>
<li><a class="" href="reagents-1.html">Reagents</a></li>
<li><a class="" href="test-procedures.html">Test Procedures</a></li>
<li class="book-part">Transfusion Practice</li>
<li><a class="" href="indications.html">Indications</a></li>
<li><a class="" href="component-therapy.html">Component Therapy</a></li>
<li><a class="" href="adverse-effects.html">Adverse Effects</a></li>
<li><a class="" href="immunologic.html">Immunologic</a></li>
<li><a class="" href="nonimmunologic.html">Nonimmunologic</a></li>
<li><a class="" href="ttds.html">TTDs</a></li>
<li><a class="" href="apheresis-extracorporeal-circulation.html">Apheresis &amp; Extracorporeal Circulation</a></li>
<li><a class="" href="blood-administration-patient-blood-management.html">Blood Administration &amp; Patient Blood Management</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="prevention" class="section level1 unnumbered">
<h1>Prevention<a class="anchor" aria-label="anchor" href="#prevention"><i class="fas fa-link"></i></a>
</h1>
<p>This is truly one of the great success stories in transfusion medicine! Preventing Hemolytic Disease of the Fetus and Newborn (HDFN), particularly the severe form caused by anti-D, relies almost entirely on preventing the <strong>mother</strong> from becoming <strong>alloimmunized</strong> (sensitized) to the specific fetal red blood cell antigen in the first place</p>
<div id="the-cornerstone-rh-immune-globulin-rhig-prophylaxis-for-anti-d" class="section level2 unnumbered">
<h2>
<strong>The Cornerstone: Rh Immune Globulin (RhIG) Prophylaxis for Anti-D</strong><a class="anchor" aria-label="anchor" href="#the-cornerstone-rh-immune-globulin-rhig-prophylaxis-for-anti-d"><i class="fas fa-link"></i></a>
</h2>
<p>This strategy focuses specifically on preventing RhD-negative individuals from developing anti-D antibodies after exposure to RhD-positive red blood cells</p>
<ul>
<li>
<strong>What is RhIG?:</strong> A sterile solution containing concentrated <strong>IgG anti-D antibodies</strong>, derived from the plasma of screened human donors who have high levels of anti-D. It’s a form of <strong>passive immunization</strong>
</li>
<li>
<strong>Mechanism of Action (How it Prevents Sensitization):</strong> The exact mechanism is complex, but the leading theory involves <strong>immune clearance and suppression</strong>:
<ol style="list-style-type: decimal">
<li>When RhD-positive fetal red blood cells enter the RhD-negative mother’s circulation (Fetal-Maternal Hemorrhage - FMH), the injected RhIG antibodies (passive anti-D) quickly bind to the D antigens on these fetal cells</li>
<li>These antibody-coated fetal cells are rapidly cleared from the maternal circulation, primarily by macrophages in the spleen, likely via Fc receptor interactions</li>
<li>This rapid clearance occurs <em>before</em> the mother’s own adaptive immune system (B cells and T cells) has a chance to fully recognize the foreign D antigen and mount its own active, long-lasting immune response (i.e., produce her own anti-D and form memory cells)</li>
<li>Essentially, the passive antibody “masks” the antigen and facilitates its removal, preventing primary immunization</li>
</ol>
</li>
<li>
<strong>Crucial Point:</strong> RhIG is <strong>prophylactic</strong>, meaning it <em>prevents</em> sensitization. It is <strong>NOT effective</strong> if the mother has <em>already</em> developed her own anti-D antibodies (i.e., is already alloimmunized)</li>
</ul>
</div>
<div id="standard-administration-protocols-for-rhig" class="section level2 unnumbered">
<h2>
<strong>Standard Administration Protocols for RhIG</strong><a class="anchor" aria-label="anchor" href="#standard-administration-protocols-for-rhig"><i class="fas fa-link"></i></a>
</h2>
<p>To be effective, RhIG must be given strategically around times when FMH is likely to occur</p>
<ul>
<li>
<strong>Antenatal Prophylaxis (Routine)</strong>
<ul>
<li>
<strong>When:</strong> A standard dose (typically 300 µg in the US) is recommended for <strong>ALL RhD-negative, unsensitized (anti-D negative) pregnant women</strong> around <strong>28 weeks of gestation</strong>
</li>
<li>
<strong>Why:</strong> Recognizes that small, often silent, FMHs can occur during the third trimester, potentially sensitizing the mother before delivery. This dose provides passive protection for the remainder of the pregnancy</li>
</ul>
</li>
<li>
<strong>Postnatal Prophylaxis</strong>
<ul>
<li>
<strong>When:</strong> A standard dose (e.g., 300 µg) is given to the <strong>RhD-negative, unsensitized mother</strong> within <strong>72 hours</strong> after the delivery of an <strong>RhD-positive infant</strong>
</li>
<li>
<strong>Why:</strong> Delivery is associated with the highest risk and potentially largest volume of FMH. The 72-hour window is critical to intercept any fetal cells before the mother’s immune response is fully initiated</li>
<li>
<strong>Confirmation:</strong> The infant’s RhD type is determined from cord blood testing at birth</li>
</ul>
</li>
<li>
<strong>After Other Potential Sensitizing Events:</strong> RhIG is also recommended for RhD-negative, unsensitized women following any event during pregnancy that could potentially cause FMH, including:
<ul>
<li>Amniocentesis, Chorionic Villus Sampling (CVS), Fetal Blood Sampling (FBS)</li>
<li>Miscarriage, therapeutic abortion, ectopic pregnancy</li>
<li>Significant abdominal trauma</li>
<li>External cephalic version (attempting to turn a breech baby)</li>
<li>Antepartum bleeding</li>
<li>
<em>Dose Consideration:</em> Smaller doses (e.g., 50 µg) may be sufficient for events occurring in the first trimester</li>
</ul>
</li>
</ul>
</div>
<div id="detecting-and-managing-excessive-fetal-maternal-hemorrhage-fmh" class="section level2 unnumbered">
<h2>
<strong>Detecting and Managing Excessive Fetal-Maternal Hemorrhage (FMH)</strong><a class="anchor" aria-label="anchor" href="#detecting-and-managing-excessive-fetal-maternal-hemorrhage-fmh"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>The Problem:</strong> The standard 300 µg dose of RhIG reliably protects against sensitization from an FMH of approximately <strong>15 mL of fetal RBCs</strong> (or about 30 mL of fetal whole blood)</li>
<li>
<strong>The Risk:</strong> Occasionally, a much larger FMH can occur, especially during a complicated delivery or trauma. If the FMH exceeds 15 mL of fetal RBCs, the standard dose of RhIG may be insufficient, and the mother could still become sensitized</li>
<li>
<strong>The Solution: Screening and Quantification</strong>
<ul>
<li>
<strong>Screening Test (Qualitative): Rosette Test</strong>
<ul>
<li>Performed on a post-delivery maternal blood sample (from an RhD-negative mother delivering an RhD-positive infant)</li>
<li>Principle: Maternal sample is incubated with reagent anti-D. If D-positive fetal cells are present, the anti-D coats them. Indicator D-positive cells are added, which bind to the antibody-coated fetal cells, forming visible clusters or “rosettes” around the fetal cells when viewed microscopically</li>
<li>Interpretation: A positive rosette test suggests an FMH potentially larger than 15 mL of RBCs and indicates the need for a quantitative test</li>
</ul>
</li>
<li>
<strong>Quantitative Test: Kleihauer-Betke (KB) Stain or Flow Cytometry</strong>
<ul>
<li>
<strong>Kleihauer-Betke (KB) Stain:</strong> Classic method. Based on the principle that fetal hemoglobin (HbF) is resistant to acid elution, while adult hemoglobin (HbA) is not. A maternal blood smear is treated with acid buffer, lysing adult cells but leaving fetal cells intact. The smear is stained, and fetal cells (containing HbF) appear bright pink/red, while adult “ghost” cells are pale. The percentage of fetal cells is counted microscopically</li>
<li>
<strong>Flow Cytometry:</strong> More accurate, objective, and reproducible method. Uses fluorescently labeled antibodies against HbF (or sometimes anti-D) to quantify the proportion of fetal cells in the maternal sample</li>
</ul>
</li>
<li>
<strong>Calculating Additional RhIG Dose</strong>
<ol style="list-style-type: decimal">
<li>Determine the percentage of fetal cells (from KB or flow)</li>
<li>Calculate the volume of FMH (whole blood): <code>% Fetal Cells x Maternal Blood Volume (est. 5000 mL)</code>
</li>
<li>Calculate the volume of fetal RBCs: <code>Volume of FMH (WB) x Fetal Hct (estimated or use 0.5)</code> <em>[Simpler calculation often used: `% Fetal Cells x 50 = mL of Fetal WB]</em>
</li>
<li>Determine the number of 300 µg RhIG vials needed: <code>Volume of Fetal RBCs / 15 mL per vial</code> (or <code>Volume of Fetal WB / 30 mL per vial</code>)</li>
<li>
<strong>Always round up</strong> to the next whole vial and <strong>add one extra vial</strong> as a safety margin
<em>Example:</em> KB shows 1% fetal cells. FMH = 0.01 x 5000 mL = 50 mL WB. Vials needed = (50 mL WB / 30 mL per vial) = 1.67 -&gt; Round up to 2 vials, add 1 extra = <strong>3 vials total</strong>
</li>
</ol>
</li>
<li>
<strong>Administration:</strong> The calculated dose of RhIG should be given within 72 hours of the sensitizing event (delivery)</li>
</ul>
</li>
</ul>
</div>
<div id="prevention-of-hdfn-due-to-other-blood-group-antibodies" class="section level2 unnumbered">
<h2>
<strong>Prevention of HDFN Due to Other Blood Group Antibodies</strong><a class="anchor" aria-label="anchor" href="#prevention-of-hdfn-due-to-other-blood-group-antibodies"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>The Challenge:</strong> Currently, <strong>there is NO equivalent immune globulin prophylaxis</strong> available to prevent sensitization to other clinically significant red cell antigens like K, c, E, Fy<sup>a</sup>, Jk<sup>a</sup>, etc</li>
<li>
<strong>Preventative Strategies (Limited)</strong>
<ul>
<li>
<strong>Transfusion Practices:</strong> The most effective strategy is careful transfusion practice for women of childbearing potential:
<ul>
<li>Avoid unnecessary transfusions</li>
<li>If transfusion is required, provide <strong>antigen-negative units</strong> whenever possible, especially for highly immunogenic antigens like K (i.e., give K-negative blood to K-negative individuals) and potentially Rh antigens (c, E) for RhD-positive women. This reduces the chance of primary alloimmunization via transfusion</li>
</ul>
</li>
<li>
<strong>Early Detection:</strong> While not prevention of sensitization, early detection of these antibodies during routine prenatal antibody screening allows for appropriate monitoring and management of the pregnancy if the fetus is at risk</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-66" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-66"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Rh Immune Globulin (RhIG):</strong> A solution of concentrated IgG anti-D antibodies used to prevent RhD alloimmunization in RhD-negative individuals</li>
<li>
<strong>Alloimmunization (Sensitization):</strong> The development of antibodies against foreign antigens from the same species</li>
<li>
<strong>Prophylaxis:</strong> Action taken to prevent disease</li>
<li>
<strong>Passive Immunization:</strong> Providing temporary immunity by administering pre-formed antibodies (like RhIG)</li>
<li>
<strong>Fetal-Maternal Hemorrhage (FMH):</strong> Leakage of fetal blood into the maternal circulation</li>
<li>
<strong>Rosette Test:</strong> A qualitative screening test used to detect FMH exceeding the coverage of a standard RhIG dose</li>
<li>
<strong>Kleihauer-Betke (KB) Stain:</strong> A quantitative test using acid elution to determine the percentage of fetal red blood cells (containing HbF) in a maternal blood sample</li>
<li>
<strong>Flow Cytometry (for FMH):</strong> An automated quantitative method using fluorescent antibodies to detect and quantify fetal cells in maternal blood</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();
  
  // hide those labes that take up multiple lines
  l = [];
  function hide_label() {
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase" 
          && 
          !elem.classList
          .contains('book-part') 
          ? l.push(elem) 
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    count = 0;
    prev_elem = '';
    l.forEach((elem) => {
      if(count === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_elem.classList.add('hide_label');
        } else {
          prev_elem.classList.remove('hide_label');
        }
      }
      prev_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="treatment.html">Treatment</a></div>
<div class="next"><a href="cytopenias-1.html">Cytopenias</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#prevention">Prevention</a></li>
<li><a class="nav-link" href="#the-cornerstone-rh-immune-globulin-rhig-prophylaxis-for-anti-d">The Cornerstone: Rh Immune Globulin (RhIG) Prophylaxis for Anti-D</a></li>
<li><a class="nav-link" href="#standard-administration-protocols-for-rhig">Standard Administration Protocols for RhIG</a></li>
<li><a class="nav-link" href="#detecting-and-managing-excessive-fetal-maternal-hemorrhage-fmh">Detecting and Managing Excessive Fetal-Maternal Hemorrhage (FMH)</a></li>
<li><a class="nav-link" href="#prevention-of-hdfn-due-to-other-blood-group-antibodies">Prevention of HDFN Due to Other Blood Group Antibodies</a></li>
<li><a class="nav-link" href="#key-terms-66">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/blob/main/Rmd/03-B-03-d.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/edit/main/Rmd/03-B-03-d.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-04-07 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
